References
- Abbaspour N, Hurrell R, Kelishadi R. 2014. Review on iron and its importance for human health. J Res Med Sci. 19(2):164–174.
- Bohn MK, Lippi G, Horvath A, Sethi S, Koch D, Ferrari M, Wang C-B, Mancini N, Steele S, Adeli K. 2020. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med. 58(7):1037–1052. doi:https://doi.org/10.1515/cclm-2020-0722.
- Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, Li Z, Zhou G, Gou J, Qu J, et al. 2020. COVID-19: abnormal liver function tests. J Hepatol. 73(3):566–574. doi:https://doi.org/10.1016/j.jhep.2020.04.006
- Cao X. 2020. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 20(5):269–270. doi:https://doi.org/10.1038/s41577-020-0308-3.
- Carter LJ, Garner LV, Smoot JW, Li Y, Zhou Q, Saveson CJ, Sasso JM, Gregg AC, Soares DJ, Beskid TR, et al. 2020. Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci. 6(5):591–605. doi:https://doi.org/10.1021/acscentsci.0c00501
- Casadevall A, Pirofski L-A. 2020. The convalescent sera option for containing COVID-19. J Clin Invest. 130(4):1545–1548. doi:https://doi.org/10.1172/JCI138003.
- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 395(10223):507–513. doi:https://doi.org/10.1016/S0140-6736(20)30211-7
- Fan Z, Chen L, Li J, Cheng X, Yang J, Tian C, Zhang Y, Huang S, Liu Z, Cheng J. 2020. Clinical features of COVID-19-related liver functional abnormality. Clin Gastroenterol Hepatol. 18(7):1561–1566. doi:https://doi.org/10.1016/j.cgh.2020.04.002.
- Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, Asa SL, Faure P, Akhavan P, Low DE, Kain KC. 2005. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis. 191(2):193–197. doi:https://doi.org/10.1086/426870.
- Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, Liu L, Shan H, Lei C-L, Hui DSC, et al. 2020. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 382(18):1708–1720. doi:https://doi.org/10.1056/NEJMoa2002032
- Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. 2020. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 14:1753466620937175. doi:https://doi.org/10.1177/1753466620937175.
- Jiang S, Du L, Shi Z. 2020a. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microbes Infect. 9(1):275–277. doi:https://doi.org/10.1080/22221751.2020.1723441.
- Jiang S, Xia S, Ying T, Lu L. 2020b. A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome. Cell Mol Immunol. 17(5):554. doi:https://doi.org/10.1038/s41423-020-0372-4.
- Jin A, Yan B, Hua W, Feng D, Xu B, Liang L, Guo C. 2020. Clinical characteristics of patients diagnosed with COVID-19 in Beijing. Biosaf Health. 2(2):104–111. doi:https://doi.org/10.1016/j.bsheal.2020.05.003.
- Jolliffe IT. 2002. Principal component analysis. second ed. New York: Springer-Verlag New York, Inc.
- Kim D, Lee J-Y, Yang J-S, Kim JW, Kim VN, Chang H. 2020. The architecture of SARS-CoV-2 transcriptome. Cell. 181(4):914–921.e910. doi:https://doi.org/10.1016/j.cell.2020.04.011.
- Klein SL, Flanagan KL. 2016. Sex differences in immune responses. Nat Rev Immunol. 16(10):626–638. doi:https://doi.org/10.1038/nri.2016.90.
- Koozi H, Lengquist M, Frigyesi A. 2020. C-reactive protein as a prognostic factor in intensive care admissions for sepsis: A Swedish multicenter study. J Crit Care. 56:73–79.
- Kovats S. 2015. Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol. 294(2):63–69.
- Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. 2020. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 14(4):535–545.
- Lalueza A, Ayuso B, Arrieta E, Trujillo H, Folgueira D, Cueto C, Serrano A, Laureiro J, Arévalo-Cañas C, Castillo C, et al. 2020. Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection. Clin Microbiol Infect. 26(11):1557.e1559-1557.e1515.
- Li H, Wang Y, Ji M, Pei F, Zhao Q, Zhou Y, Hong Y, Han S, Wang J, Wang Q, et al. 2020. Transmission routes analysis of SARS-CoV-2: a systematic review and case report. Front Cell Dev Biol. 8:618.
- Linkins LA, Takach Lapner S. 2017. Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol. 39(Suppl 1):98–103.
- Lippi G, Lavie CJ, Sanchis-Gomar F. 2020. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis. 63(3):390–391.
- Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, Li B, Song X, Zhou X. 2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 127:104370.
- Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, Shen J, Zhu LR, Chen Y, Iacucci M, et al. 2020. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 5(7):667–678.
- McDonald JH. 2008. Handbook of biological statistics. Baltimore: Sparky House Publishing.
- Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. 2020. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 395(10229):1033–1034.
- Paliogiannis P, Zinellu A, Scano V, Mulas G, De Riu G, Pascale RM, Arru LB, Carru C, Pirina P, Mangoni AA, et al. 2020. Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report. J Infect Dev Countr. 14(7):685–690.
- Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, Nguyen TT, Cao TM, Pham QD. 2020. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. 382(9):872–874.
- Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. 2020. SARS-CoV-2 and coronavirus disease 2019: what we know so far. Pathogens (Basel, Switzerland). 9(3):231–245.
- Ryoo SM, Han KS, Ahn S, Shin TG, Hwang SY, Chung SP, Hwang YJ, Park YS, Jo YH, Chang HL, et al. 2019. The usefulness of C-reactive protein and procalcitonin to predict prognosis in septic shock patients: A multicenter prospective registry-based observational study. Sci Rep. 9(1):6579.
- Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Hosein Z, Padda I, Mangat J, Altaf M. 2020. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2:1069–1076.
- Sethuraman N, Jeremiah SS, Ryo A. 2020. Interpreting diagnostic tests for SARS-CoV-2. JAMA. 323(22):2249–2251.
- Shah P, Doshi R, Chenna A, Owens R, Cobb A, Ivey H, Newton S, McCarley K. 2020. Prognostic value of elevated cardiac troponin i in hospitalized Covid-19 patients. Am J Cardiol. 135:150–153.
- Simon H. 2010. Mars vs. Venus: the gender gap in health. Harvard Men’s Health Watch. 14(6):1–5.
- Sproston NR, Ashworth JJ. 2018. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 9:754.
- Tan J, Liu S, Zhuang L, Chen L, Dong M, Zhang J, Xin Y. 2020. Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection. Future Virol. 15(6):373–380.
- Tang N, Li D, Wang X, Sun Z. 2020. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 18(4):844–847.
- Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T. 2020. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 18(5):1023–1026.
- Vargas-Vargas M, Cortés-Rojo C. 2020. Ferritin levels and COVID-19. Rev Panam Salud Publica. 44:e72–e72.
- Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, Benachi A, De Luca D. 2020. Transplacental transmission of SARS-CoV-2 infection. Nat Communicat. 11(1):3572.
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. 2020a. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 323(11):1061–1069.
- Wang W, Tang J, Wei F. 2020b. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 92(4):441–447.
- WHO. 2020a. Geneva: 2020. Coronavirus disease 2019 (COVID-19) situation report 51. Accessed 2020 Aug 07. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10
- WHO. 2020b. How COVID-19 spreads 27 March 2020, . accessed 2020 Aug 07. https://www.who.int/docs/default-source/coronaviruse/risk-comms-updates/update-20-epi-win-covid19.pdf?sfvrsn=5e0b2d74_2
- Wu YC, Chen CS, Chan YJ. 2020. The outbreak of COVID-19: an overview. JCMA. 83(3):217–220.
- Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L, Wang Y, Guo X. 2020. Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses. 12:2.
- Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. 2020. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 75(7):1730–1741.
- Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, et al. 2020. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 81(2):e16–e25.
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. 2020a. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 395(10229):1054–1062.
- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al. 2020b. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579(7798):270–273.